Healios Kk (4593.T) traded up 0.75 % during a 24 hours period ending at 12:29 PM Central Europe on Tuesday 27th. One Healios Kk stock can currently be bought for about JPY 279 on popular exchanges. Current supply of Healios Kk stocks is 135 mn. Healios Kk has a current market capitalization of JPY 36.5 bn and approximately JPY 279 mn worth of Healios Kk was traded on exchanges in the last 24 hours. Since last month end, Healios Kk has traded -5.59 % down. Simple moving average of last 200 days is at JPY 316.48. The highest price of past 52 weeks was recorded at JPY 508 on 10/29/2025. 52 weeks low was at JPY 208 on 07/29/2026.

Here is how related stocks have performed in the past 24 hours:

  • Key Coffee (2594.T) traded up 0.5 % and now trades at JPY 2,001. Current market capitalisation for Key Coffee is JPY 43.2 bn. Key Coffee has a current price to earnings ratio of 33.33.

  • Nippon Chemi-con (6997.T) traded down -1.01 % and now trades at JPY 1,636. Nippon Chemi-con has a market capitalisation of JPY 43.3 bn. Current price/earnings ratio for Nippon Chemi-con is 16.29.

  • Yondoshi (8008.T) traded down -0.39 % and now trades at JPY 1,998. Yondoshi has a market capitalisation of JPY 43.6 bn. Yondoshi has a current price to earnings ratio of 16.88.

  • Bookoff (9278.T) traded down -0.53 % and now trades at JPY 2,413. Current market capitalisation for Bookoff is JPY 43.5 bn. Current price/earnings ratio for Bookoff is 14.19.

  • Daiichi Kigenso Kagaku-kogyo (4082.T) traded up 3.04 % and now trades at JPY 1,814. Current market capitalisation for Daiichi Kigenso Kagaku-kogyo is JPY 43.3 bn. Daiichi Kigenso Kagaku-kogyo has a current price to earnings ratio of 12.56.

About Healios Kk

Healios K.K., a company headquartered in Tokyo, Japan, specializes in cell therapy and regenerative medicine research and development, as well as their manufacturing. The company has license agreements with other biotechnology companies like Athersys for the development of regenerative medicine products. Healios K.K. was previously known as Retina Institute Japan, K.K., but changed its name to Healios K.K. in September 2013. The IPO of the company took place on June 16, 2015, at the Tokyo Stock Exchange. The company’s website is www.healios.co.jp , and they are involved in the health care sector, with a focus on biotechnology.